No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...

Descripción completa

Detalles Bibliográficos
Autores principales: Misof, Barbara M., Roschger, Paul, Zhou, Hua, Nieves, Jeri W., Bostrom, Mathias, Cosman, Felicia, Lindsay, Robert, Klaushofer, Klaus, Dempster, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090359/
https://www.ncbi.nlm.nih.gov/pubmed/32215284
http://dx.doi.org/10.1016/j.bonr.2020.100253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090359/
https://www.ncbi.nlm.nih.gov/pubmed/32215284
http://dx.doi.org/10.1016/j.bonr.2020.100253

Ejemplares similares